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Abstract
There has been a recent surge in the use of silver as an antimicrobial agent in a wide range of domestic and clinical
products, intended to prevent or treat bacterial infections and reduce bacterial colonization of surfaces. It has been reported
that the antibacterial and cytotoxic properties of silver are affected by the assay conditions, particularly the type of growth
media used in vitro. The toxicity of Ag+ to bacterial cells is comparable to that of human cells. We demonstrate that
biologically relevant compounds such as glutathione, cysteine and human blood components significantly reduce the
toxicity of silver ions to clinically relevant pathogenic bacteria and primary human dermal fibroblasts (skin cells). Bacteria are
able to grow normally in the presence of silver nitrate at .20-fold the minimum inhibitory concentration (MIC) if Ag+ and
thiols are added in a 1:1 ratio because the reaction of Ag+ with extracellular thiols prevents silver ions from interacting with
cells. Extracellular thiols and human serum also significantly reduce the antimicrobial activity of silver wound dressings
Aquacel-Ag (Convatec) and Acticoat (Smith & Nephew) to Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia
coli in vitro. These results have important implications for the deployment of silver as an antimicrobial agent in
environments exposed to biological tissue or secretions. Significant amounts of money and effort have been directed at the
development of silver-coated medical devices (e.g. dressings, catheters, implants). We believe our findings are essential for
the effective design and testing of antimicrobial silver coatings.
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Introduction
In recent years, the emergence and persistence of bacterial
strains with resistance to multiple classes of antibiotics has led to
renewed interest in the antimicrobial properties of silver. There
has been a surge in the number of products on the market, both
domestic and clinical, that contain antimicrobial silver compounds
or nanoparticles. These include anti-odor fabric coatings, deodor-
ants, washing machine filters, laptop coatings, topical burn creams,
wound dressings and medical devices [1–3]. The development of
improved antimicrobial silver coatings and silver nanoparticles
continues to receive significant research funding worldwide [4–6].
A key aim of this research is to ensure that silver ions are released
at a sufficient rate and concentration to be effective as an
antimicrobial at levels that are safe for use. This is particularly
important for the development of medical devices, such as wound
dressings, catheters, bone implants and cardiovascular stents,
which are typically tested first in vitro (antimicrobial assays and
human cell culture) and later in vivo (animal models and clinical
trials). Topical silver solutions (0.5% silver nitrate) and creams (1%
silver sulfadiazine) have been used in the prevention and treatment
of wound infections for several decades, but these preparations
need to be reapplied frequently in order to penetrate wound tissues
due to rapid complexation of silver with wound exudates [7].
Modern advances in silver delivery methods have seen the
introduction of sustained release dressings such as the nanocrystal-
line wound dressing Acticoat (Smith & Nephew) and the hydrogel
dressing Aquacel-Ag (Convatec). These dressings should release
sufficient Ag+ to prevent or reduce bacterial colonization of the
wound bed and support efficient healing. Silver coatings on
indwelling medical devices have also been developed, such as the
Bardex IC Foley catheter (Bard Medical). These coatings should
release sufficient silver to reduce or prevent bacterial attachment
and formation of biofilms whilst inducing minimal damage to
surrounding human cells and tissue [8]. However, differences in
experimental conditions and procedures can make comparisons of
antimicrobial efficacy and human toxicity from in vitro and in vivo
experiments difficult [9–11]. A recent study by Greulich et al. used
identical growth conditions for bacteria and human cells and this
revealed that the antibacterial and cytotoxic properties of both
silver ions (silver acetate) and silver nanoparticles are within the
same range [10].
Several studies have shown the antibacterial and cytotoxic
properties of silver are affected by the assay conditions, including
the type of growth media and growth supplements such as fetal calf
serum [12]. Only a few studies have explored the chemistry behind
these differences. Liau et al. showed that compounds containing
thiol groups reduce the toxicity of silver to Pseudomonas aeruginosa
[13]. Similarly, equimolar concentrations of the thiol containing
amino acid cysteine reduce the toxicity of silver to Staphylococcus
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epidermidis [14]. The major blood protein serum albumin reduces
both the antimicrobial and cytotoxic properties of silver nanopar-
ticles embedded in hydrogels, although the mechanism of
inactivation is not known [15].
Whilst the majority of the thiol groups in the proteins of human
cells are in the oxidized state (forming disulphide bridges between
cysteine residues in proteins), the thiol groups of bacterial
cytoplasmic proteins are mostly in the reduced state due to the
redox conditions in the prokaryotic cytoplasm [16]. Animals and
bacteria have a thiol based antioxidant system that protects
cellular components against oxidative damage from reactive
oxygen species (ROS) and free radicals. In humans and many
Gram-negative bacteria, such as Escherichia coli and P. aeruginosa,
the system utilizes the tripeptide glutathione as the predominant
antioxidant. Glutathione is synthesized by specific enzymes from
the amino acids glutamate, glycine and cysteine [17,18]. Following
oxidation by ROS, the oxidized glutathione (GSSG) is recycled
back to the reduced form (GSH) by the enzyme glutathione
reductase using NADPH as an electron donor. In other bacteria
such as S. aureus and Bacillus spp. that cannot synthesize
glutathione, the predominant cellular antioxidant is typically a
low molecular weight compound synthesized from cysteine
[19,20].
In this study we present the first detailed analysis of the extent to
which biologically relevant compounds such as glutathione,
cysteine and human blood components affect toxicity of silver
ions to clinically relevant pathogenic bacteria in comparison to
human dermal fibroblasts (skin cells). We used the notorious
nosocomial opportunistic pathogens S. aureus and P. aeruginosa in
these studies as they are frequently exposed to silver-coated
dressings and catheters in clinical settings. Our findings have
important implications for the future deployment of silver as an
antimicrobial agent in environments exposed to biological tissue or
secretions.
Materials and Methods
Chemicals and Reagents
Silver nitrate, sodium nitrate, GSH, GSSG, amino acids,
human serum albumin and human serum were purchased from
Sigma Aldrich and stock solutions were prepared fresh for each
assay in sterile Milli-Q water, filter sterilized at 0.22 mm (Millex-
GS, Millipore). Propidium iodide and NucBlue (a cell permeable
form of Hoechst 33347) were diluted to the recommended working
concentration in Dulbecco’s phosphate buffered saline (DPBS +
calcium, magnesium, glucose and pyruvate), all purchased from
Life Technologies.
Bacterial growth and microbiological assays
Escherichia coli K12, P. aeruginosa PA01 [21], S. aureus MSSA476
and MRSA252 [22] were recovered from frozen (280uC) glycerol
(15% v/v) stocks on Luria Bertani (LB) agar plates at 37uC for 24
hr. Single colonies were grown in 10 mL LB broth, 250 rpm, at
37uC for 16–18 hr. Bacteria were then sub-cultured (1:100) in
10 mL LB broth, 250 rpm, at 37uC for 2–5 hr to exponential
phase (OD600 0.4–0.6). Cultures were adjusted to OD600 = 0.3
and diluted in LB (1:50) prior to use in microbiological assays
unless otherwise stated.
Stock solutions of chemicals were diluted in sterile Milli-Q water
at 506 the concentration desired in the assay. These were then
diluted 1:25 in LB broth, human serum albumin 100 mg/mL
dissolved in LB, or 100% human serum where stated. 100 mL of
this 26 solution was aliquoted into the appropriate wells of a 96-
well flat-bottom transparent plate (Greiner) with 100 mL of
bacterial culture prepared as described above (equivalent to
,56105 bacteria/well) in technical duplicates, with three biolog-
ical replicates for each strain. Microplates were incubated in a
Fluostar Omega plate reader (BMG) for 24 hr, with continuous
orbital shaking at 300 rpm, and absorbance measurements taken
at 600 nm every 6 min (20 flashes/well/cycle). The optical density
of each individual culture at 16 hr or 24 hr was plotted in
OriginPro8 (OriginLab) and Sigmoidal curves fitted using the
Boltzman function. Fitted values for each individual curve were
used to calculate the mean minimum inhibitory concentration
(MIC).
To test the effect of R-SH on the antimicrobial activity of
wound dressings, 20 mL molten LB agar (42uC) was inoculated
with approximately 16105 bacterial cells and 200 uL of the
appropriate concentration of GSH, mixed well and poured into a
standard 90 mm Petri dish. For human serum tests, 2 mL molten
LB agar (42uC) was mixed with 2 mL human serum and
approximately 26104 bacterial cells and poured into wells in a
6-well tissue culture dish (Corning). Squares (1.25 cm61.25 cm) of
Aquacel (Convatec), Aquacel-Ag (Convatec) and Acticoat (Smith
& Nephew) dressings were applied to the surface of the solidified
agar. Plates were incubated for 24 hr at 37uC and the zones of
inhibition surrounding the dressings were measured (n = 3).
Statistical significance was calculated using Student’s t-test.
Human cell culture and cytotoxicity assays
Primary adult human dermal fibroblasts were purchased from
the American Type Culture Collection (PCS-201-012). All
incubations were at 37uC, 5% CO2/95% air in a humidified
incubator. Cells were cultured in 75 cm2 tissue culture flasks in
Medium 106 supplemented with low serum growth supplement
(Life Technologies) to a confluence of ,80% for up to 8 passages.
Cells were detached from tissue culture flasks using trypsin-EDTA
and trypsin neutralizer solution as per the manufacturer’s protocol
(Life Technologies).
For cytotoxicity tests, cells were seeded at 56103 cells/cm2 in
24-well dishes with 500 mL media per well and grown to a
confluence of ,80% with media replaced every 24 hr for 2–3
days. Stock solutions of silver nitrate and GSH were diluted 1:50 in
Medium 106 supplemented with low serum growth supplement
(NB. the pH of the culture medium was not affected). Plates were
incubated for 4 or 24 hr and media was replaced with 500 mL
propidium iodide solution and incubated for 20 min. This solution
was then replaced with 500 mL NucBlue solution and incubated
for 20 min. Micrograph images were captured using an EVOS fl
digital inverted microscope (Advanced Microscopy Group) with
the light microscope, DAPI light cube (excitation at 357 nm,
emission at 447 nm, to detect NucBlue stain) and RFP light cube
(excitation at 531 nm, emission at 593 nm, to detect propidium
iodide) at 620 magnification. Stained nuclei were counted in
captured images using ImageJ [23] with means and standard
errors of the mean calculated from two technical replicate images
per well and four biological replicates per condition. The
percentages of viable cells (ratio of cells stained with propidium
iodide vs. NucBlue) were plotted in OriginPro8 (OriginLab) and
Sigmoidal curves fitted using the Boltzman function. Fitted values
representing a 50% reduction in viability for each individual curve
were used to calculate the mean cytotoxic concentration (CC50).
Quantification of silver
Overnight cultures of S. aureus were sub-cultured in 50 mL LB
broth in sterile 250 mL Erlenmeyer flasks and grown for 2–3 hr at
Inactivation of Silver Toxicity: A Cautionary Tale
PLOS ONE | www.plosone.org 2 April 2014 | Volume 9 | Issue 4 | e94409
37uC with aeration (250 rpm shaking), to OD600 0.5–0.8. 10 mL
aliquots of culture were diluted 1:2 into LB with or without
AgNO3 and with or without GSH to a final concentration of
1 mmol dm23. Cultures were incubated for 1 hr at 37uC, 250 rpm
and cells harvested by centrifugation at 4uC. The supernatant was
discarded, cell pellets were washed 36 in 1 mL PBS and re-
suspended in 200 mL 70% ethanol. Samples were boiled at 90uC
for 1 hr to lyse the cells and dry the pellets. Pellets were weighed,
re-suspended in 3 mL nH20 and transferred to digestion tubes.
10.5 mL concentrated hydrochloric acid and 3.5 mL concentrated
nitric acid was added to each sample to cold digest overnight.
Samples were heated to 140uC for 2.5 hr, allowed to cool, and
filtered through Cu impregnated filter papers (prepared by soaking
Whatman no. 540 filter paper in 0.1 M copper nitrate and rinsing
36 in nH2O). Samples were made to volume in 100 mL
volumetric flasks with 0.5 M nitric acid and diluted 1:2 with
nH20 prior to analysis by ICP-OES. Three blank samples were
prepared without cell pellets as negative controls to set the
detection limit.
Results
Antibacterial activity of silver nitrate in different
conditions
The pathogenic clinical isolates S. aureus MSSA476 and P.
aeruginosa PA01 were grown overnight in LB broth with a range of
concentrations of silver nitrate, which readily dissolves in culture
media to Ag+ and NO3
2. Each increase in the concentration of
silver nitrate below the minimum inhibitory concentration (MIC)
resulted in a prolonged lag phase (i.e. the time between the
inoculation of bacteria and the onset of exponential growth) for
both strains, but once growth had initiated the growth rate was
then comparable to that in LB (Fig. 1A and 2A). The MIC of silver
nitrate in LB broth was 33 mmol dm23 to S. aureus MSSA476,
13 mmol dm23 to P. aeruginosa PA01 and 37 mmol dm23 to E. coli
K12, at 16 hr (Table 1). A methicillin resistant S. aureus strain,
MRSA252, was also tested and the MIC was equivalent to that of
MSSA476. We found that the MIC was not affected by the
number of bacteria in the starting inoculum as 10-fold dilutions of
bacteria from 16106 to 16102 bacteria per well resulted in
comparable MIC values.
Figure 1. The effect of silver nitrate on the growth of Staphylococcus aureus MSSA476 in different media. AgNO3 was added to growth
media at the indicated concentrations (mmol dm23) in (A) LB; (B) LB + 50 mg/mL HSA; (C) LB + 50% human serum (v/v); (D) LB + 1 mmol dm23 GSH.
GSH, reduced glutathione; HSA, human serum albumin (the major blood protein). Error bars = SD, n = 3.
doi:10.1371/journal.pone.0094409.g001
Inactivation of Silver Toxicity: A Cautionary Tale
PLOS ONE | www.plosone.org 3 April 2014 | Volume 9 | Issue 4 | e94409
Coatings on medical devices such as bandages and catheters
contact human blood and tissue. To assess whether the
components of blood affect the antimicrobial efficacy of silver
ions, the MIC of silver was determined in LB supplemented with
human serum (blood depleted of cells and clotting factors) and
human serum albumin (HSA, the major blood protein present in
serum). Both of these blood components increased the MIC of
AgNO3 to S. aureus (Figure 1B and 1C) and P. aeruginosa (Figure 2B
and 2C), with serum being more potent than HSA alone indicating
the presence of additional components within serum that
inactivate Ag+ toxicity. Note that only 50% serum was used in
this experiment so the protective effect of whole blood is
Figure 2. The effect of silver nitrate on the growth of Pseudomonas aeruginosa PA01 in different media. AgNO3 was added to growth
media at the indicated concentrations (mmol dm23) in (A) LB; (B) LB + 50 mg/mL HSA; (C) LB + 50% human serum (v/v); (D) LB + 1 mmol dm23 GSH.
GSH, reduced glutathione; HSA, human serum albumin (the major blood protein). Error bars = SD, n = 3.
doi:10.1371/journal.pone.0094409.g002
Table 1. The effect of biologically relevant compounds on the minimum inhibitory concentration (MIC) and cytotoxic
concentration (CC50) of silver nitrate to bacteria and human cells.
Growth conditions P. aeruginosa mmol dm23 S. aureus mmol dm23 E. coli mmol dm23 Human Fibroblasts mmol dm23
Media only 1362 3363 3765 2361
Media + HSA 50 mg/ml 4462 158610 50610 ND
Media + human serum 50% v/v 8167 174617 ND ND
Media + 1 mmol dm23 GSH 112669 1121680 1020665 982672
The MIC of AgNO3 to P. aeruginosa, S. aureus and E. coli was determined in Luria-Bertani broth and the CC50 of AgNO3 to primary human dermal fibroblasts in Medium
106 supplemented with low serum growth supplement (6 SD, n$3). GSH, reduced glutathione; HSA, human serum albumin; ND, Not determined (conditions do not
support growth).
doi:10.1371/journal.pone.0094409.t001
Inactivation of Silver Toxicity: A Cautionary Tale
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potentially greater in vivo. The inclusion of 1 mmol dm23 GSH in
LB enabled S. aureus, P. aeruginosa and E. coli to grow in the presence
of up to, but not in excess of, 1 mmol dm23 AgNO3 (Table 1). The
lag phase and growth rate in LB with 1 mmol dm23 AgNO3 +
1 mmol dm23 GSH was remarkably similar to that in LB with
1 mmol dm23 GSH alone (Figure 1 and 2) indicating GSH causes
complete loss of silver ion toxicity in a 1:1 molar ratio. The addition
of 1 mmol dm23 cysteine to LB showed the same protective effect as
GSH enabling normal growth up to, but not in excess of, 1 mmol
dm23 AgNO3 (data not shown). This suggests that silver ions bind to
glutathione and cysteine (which both contain one thiol group) in a
1:1 ratio and that these complexes are not toxic to bacteria. In
contrast, the addition of glutamate, glycine, methionine, histidine or
cystine (cysteine disulphide) at 1 mmol dm23 did not rescue growth
of either P. aeruginosa or S. aureus at 200 mmol dm23 AgNO3 in LB.
The addition of 1 mmol dm23 GSSG was toxic (data not shown).
We speculate that the addition of excess GSSG would lead to
depletion of the cellular pool of reductant as the bacteria attempt to
convert it back to GSH. The addition of 1 mmol dm23 sodium
nitrate to LB did not affect the growth of the bacterial strains
compared to LB alone, indicating NO3
2 does not influence the
toxicity of AgNO3.
After performing these assays, the surplus media was left on the
lab bench and we noted that the LB + AgNO3 solutions became
increasingly dark brown over time, but this was prevented by the
addition of 1 mmol dm23 GSH (Figure 3) or cysteine and these
solutions remained clear for over 3 months.
Antibacterial activity of silver-coated dressings in
different conditions
Silver coated wound dressings come into contact with biological
secretions within the wound bed. The antibacterial properties of
Figure 3. Photochemical reduction of Ag+ in LB medium. AgNO3 was added to (A) LB and (B) LB + 1 mmol dm3 GSH at (i) 0 mmol dm3, (ii)
0.75 mmol dm3, (iii) 1.0 mmol dm3, (iv) 1.25 mmol dm3. GSH, reduced glutathione.
doi:10.1371/journal.pone.0094409.g003
Table 2. The effect of biologically relevant compounds on the antimicrobial efficacy of Aquacel-Ag (Convatec) wound dressings.
Growth conditions P. aeruginosa mm S. aureus mm E. coli mm
LB agar only 8.760.6 3.060.0 4.360.6
LB agar + 0.1 mmol dm23 GSH 6.360.6 * 2.060.0 2.560.5
LB agar + 0.5 mmol dm23 GSH 5.260.3 * 0.260.3 * 0.360.3 *
LB agar + 1 mmol dm23 GSH 1.760.6 * 0.060.0 * 0.060.0 *
LB agar + human serum 50% v/v 2.360.6 * 0.860.3 * ND
The average zone of inhibition (mm) surrounding 1.2561.25 cm dressing samples applied to bacterial lawns. 6 SD, n = 3, * denotes a significant difference from LB agar
only control (Student’s t-test P,0.01). GSH, reduced glutathione; LB, Luria-Bertani; ND, Not determined (conditions do not support growth).
doi:10.1371/journal.pone.0094409.t002
Table 3. The effect of biologically relevant compounds on the antimicrobial efficacy of Acticoat (Smith & Nephew) wound
dressings.
Growth conditions P. aeruginosa mm S. aureus mm E. coli mm
LB agar only 9.061.0 3.060.0 4.360.6
LB agar + 0.1 mmol dm23 GSH 7.360.6 2.260.3 * 2.560.5
LB agar + 0.5 mmol dm23 GSH 5.860.3 * 0.360.3 * 0.860.3 *
LB agar + 1 mmol dm23 GSH 4.360.6 * 0.060.0 * 0.060.0 *
LB agar + human serum 50% v/v 2.360.6 * 1.760.3 * ND
The average zone of inhibition (mm) surrounding 1.2561.25 cm dressing samples applied to bacterial lawns. 6 SD, n = 3, * denotes a significant difference from LB agar
only control (Student’s t-test P,0.01). GSH, reduced glutathione; LB, Luria-Bertani; ND, Not determined (conditions do not support growth).
doi:10.1371/journal.pone.0094409.t003
Inactivation of Silver Toxicity: A Cautionary Tale
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wound dressings can be tested in vitro by measuring the zone of
inhibition surrounding a test sample. Silver ions released from
dressings diffuse through the agar and prevent bacterial growth
where the concentration exceeds the MIC. Aquacel-Ag (Table 2)
and Acticoat (Table 3) dressings showed similar efficacies against
the test bacteria in LB agar, with P. aeruginosa displaying the largest
zone of inhibition as expected based on the greater sensitivity of
this species to silver ion toxicity (Table 1). No zones of inhibition
were observed for non-silver Aquacel dressings confirming Ag+
release is solely responsible for the inhibition of growth caused by
Aquacel-Ag and Acticoat. Increasing the concentration of GSH in
the LB agar caused a corresponding reduction in the size of the
zone of inhibition caused by both Aquacel-Ag and Acticoat. The
inclusion of human serum (50% v/v) in the agar significantly
reduced the size of the zone of inhibition to P. aeruginosa and S.
aureus (Student’s t-test P,0.001). Our results confirm that the
antimicrobial effectiveness of these dressings is significantly
reduced by the presence of extracellular R-SH and human serum
(Table 2 and 3).
Cytotoxicity of silver towards primary human fibroblasts
Fibroblasts within the dermal layer of the skin are one of the
most important cell types involved in wound healing. This is
therefore the cell line of choice for assessing cytotoxicity of silver in
wound dressings and medical devices. Primary cells are directly
acquired from donor tissue and have a limited lifespan in cell
Figure 4. Micrographs of primary adult human dermal fibroblasts exposed to silver nitrate. Cells were exposed to AgNO3 at the
indicated concentration for 24 hr: (A) 0 mmol dm23 AgNO3; (B) 10 mmol dm
23 AgNO3; (C) 25 mmol dm
23 AgNO3; (D) 750 mmol dm
23 AgNO3 +
1 mmol dm23 GSH; (E) 1 mmol dm23 AgNO3 + 1 mmol dm23 GSH. Images were captured for the same cells stained with i) NucBlue (Hoechst 33347),
which stains all cell nuclei and ii) Propidium iodide, which stains nuclei of dead cells; (iii) Light microscope images show changes in cell morphology.
GSH, reduced glutathione. Scale bar = 200 mm
doi:10.1371/journal.pone.0094409.g004
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culture. These cells are therefore preferred for cytotoxicity studies
as they more closely reflect host responses in vitro than
immortalized cell lines that may have changed significantly during
routine culture in the laboratory.
The cytotoxic concentration (CC50) of AgNO3 to primary
human dermal fibroblasts was 23 mmol dm23, which is in the same
range as the MIC to the bacteria tested in this study (Table 1).
Exposure of cells to 10 mmol dm23 AgNO3 for 24 hours had no
visible effect on cell morphology (cells remained elongated) or
viability (cell nuclei stained with NucBlue, but not propidium
iodide) and cells maintained a confluent, adherent monolayer
(Figure 4B). In contrast, cells exposed to 25 mmol dm23 AgNO3
were rounded (as opposed to elongate) and had begun to detach
from the culture plate. The nuclei of the majority of these cells
stained with propidium iodide indicating compromised cell
membrane integrity (Fig 4Cii) equating to a 60% and 95%
reduction in viability at 4 hr and 24 hr respectively (Figure 5A).
Furthermore, the nuclei of the cells stained with propidium iodide
showed signs of nuclear condensation, which is indicative of
apoptosis or ‘‘programmed cell death’’ (Figure 6). The addition of
1 mmol dm23 GSH to the cell culture medium increased the
CC50 of AgNO3 to 982 mmol dm
23 after 24 hr (Table 1,
Figure 5B). The addition of 1 mmol dm23 sodium nitrate to the
cell culture medium had no effect on cell morphology or viability
relative to controls after 24 hr, indicating nitrate does not
influence the cytotoxicity of AgNO3 (data not shown).
Mechanism of thiol protection
To determine how extracellular R-SH reduce the toxicity of
Ag+ we used ICP-OES to analyse the silver content of S. aureus
exposed to 1 mmol dm23 AgNO3 with and without the inclusion
of an equimolar concentration of GSH in LB broth. Ag was
detected in cells exposed to AgNO3 only at a concentration of
326662 fg Ag/cell and 62.865.5 mg Ag/mg cell dry weight (6
SEM, n = 4). In contrast, Ag was not detectable in cells exposed to
LB only and AgNO3 + GSH. We therefore conclude that
extracellular R-SH prevent Ag+ from binding to cells and this
inactivates Ag+ toxicity.
Discussion
Our findings prove that reduced thiol groups (R-SH) in the
extracellular environment markedly reduce the antimicrobial
efficacy and cytotoxicity of silver ions. When Ag+ and R-SH are
added in a 1:1 ratio the reaction of Ag+ with R-SH prevents Ag+
from interacting with cells thereby inactivating silver toxicity. GSH
is the predominant low molecular weight thiol in humans, present
in all cell types at a concentration of between 1 and 10 mmol
Figure 5. The cytotoxicity of silver nitrate to human skin cells. Viability of primary adult human dermal fibroblasts exposed to AgNO3 for 4 h
or 24 h in (A) Medium 106; (B) Medium 106+1 mmol dm23 GSH. Sigmoidal curves were fitted using the Boltzman function in OriginPro8 (OriginLab).
Error bars = SEM, n= 4. GSH, reduced glutathione.
doi:10.1371/journal.pone.0094409.g005
Figure 6. Nuclear condensation in human skin cells exposed to the minimum cytotoxic concentration of silver nitrate. Primary adult
human dermal fibroblasts were exposed to 20 mmol dm23 AgNO3 for 4 hr. Images were captured for the same cells: (A) Light microscope image
shows cellular morphology; (B) stained with NucBlue (Hoechst 33347), which stains all cell nuclei; (C) stained with propidium iodide, which stains
nuclei of dead cells (NB. areas of nuclear condensation are indicative of apoptosis); (D) Composite image of A, B and C. GSH, reduced glutathione.
Scale bar = 50 mm.
doi:10.1371/journal.pone.0094409.g006
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dm23 and in blood at approximately 1 mmol dm23 [24,25]. Our
results show the addition of 1 mmol dm23 GSH results in
complete loss of antibacterial activity of Aquacel-Ag (Convatec)
and Acticoat (Smith & Nephew) dressings to both S. aureus and E.
coli in vitro. Given recent evidence that the toxicity of silver
nanoparticles is dependent on the rate of dissolution of free Ag+
[6,26,27], extracellular R-SH will similarly reduce their antibac-
terial efficacy. The negative effect of complex-formation between
biological R-SH groups and Ag+ should be considered in the
future development of all novel silver coatings and nanoparticles.
In vitro testing of silver-coated dressings and medical devices should
be performed in biologically relevant media as the concentration
of R-SH in standard bacterial culture media is typically much
lower than in human blood and tissue. This is particularly relevant
to the testing of sustained-release devices as the presence of R-SH
in biological tissues could significantly affect the rate of dissolution
of Ag+ and the duration of antimicrobial efficacy. Another
consideration is that in vitro tests are typically performed in closed
systems, which could exaggerate the longevity of antimicrobial
action due to saturation of R-SH with Ag+. It seems likely that the
constant replenishment of biological fluids containing R-SH would
continue to limit the antimicrobial efficacy of Ag+ released from
dressings/devices in vivo. Furthermore, the concentration and rate
of Ag+ dissolution from antibacterial coatings on medical devices
and wound dressings should be carefully controlled to minimize
cytotoxicity towards dermal fibroblasts and other human cell types
because this could reduce the rate of wound healing, as suggested
elsewhere [28,29]. Indeed, a recent Cochrane systematic review of
the use of topical silver including silver sulphadiazine in the
treatment of burns suggested that there is insufficient clinical
evidence to support the hypothesis that such dressings do indeed
promote healing or prevent infection [30].
Whilst it was not possible to use identical culture conditions for
the bacterial and human cell assays in this study, we found that the
toxicity of AgNO3 to both bacteria and human cells was within the
same range, which is in agreement with the results of Greulich
et al. [10]. The toxicity of silver is attributed to multiple factors
including cell membrane damage, inhibition of respiratory
enzymes, perturbation of metal ion homeostasis and generation
of ROS that damage cellular components such as DNA and lipids.
Several studies have demonstrated that the major target site(s) of
Ag+ in Gram-negative bacteria are intracellular. Firstly, low-level
silver resistance by adaptation of E. coli to increasing concentra-
tions of AgNO3 was achieved by both decreased outer membrane
permeability (due to a decrease in porin proteins that form
membrane channels in the outer membrane) and active efflux of
Ag+ from the cell [31]. Secondly, all known high-level silver
resistance mechanisms in bacteria involve efflux pumps [32,33].
Only one silver efflux system has been characterised at the
molecular level to date and is encoded by the sil genes (silRSE
silCBA silP) on the pMG101 plasmid of Salmonella. This system
utilises a periplasmic Ag+-binding protein (SilE), which surprisingly
lacks cysteine residues and instead coordinates 10 silver ions per
polypeptide via 10 histidine residues [34]. The binding of silver
ions to exposed thiol groups within a cell would have two
complementary negative effects. Firstly, it might impair the
functionality of any biomolecules to which it became bound and
secondly it would reduce the cell’s ability to neutralize natural
ROS by depleting the effector molecules of the homeostatic
antioxidant system such as GSH and cysteine. This would explain
why silver ions often induce a measurable increase in intracellular
ROS in both bacterial [35] and human cells [36–38], but do not
directly generate ROS via Fenton-type reactions [35]. It should be
noted that bacterial cells are much smaller than human cells and
therefore contain less total GSH (or alternative low molecular
weight thiols) per cell. Human cells also produce several forms of
the cysteine-rich protein metallothionein (MT) that protect against
oxidative damage and metal-ion toxicity [39,40]. MT gene
expression is induced by treatment with sub-inhibitory concen-
trations of silver, suggesting a role in cytoprotection against this
specific stress [41,42]. Furthermore, the majority of cytoplasmic
proteins in a bacterium are maintained in the reduced state [16]
and should therefore be more susceptible to Ag+ binding. With this
in mind, it is surprising that bacterial cells are not much more
sensitive to Ag+ than human cells. One possible explanation is that
the most sensitive ‘‘targets’’ in bacteria and human cells lay in
common essential biological processes or pathways. Xu et al.
recently showed that silver specifically inhibits the activity of
several dehydratases in E. coli, leading to destruction of the
exposed 4Fe-4S clusters and the release of iron ions [43], which
would generate intracellular ROS via Fenton-type reactions. In
eukaryotic cells this would cause mitochondrial damage and
trigger apoptosis, as observed in response to silver treatment
[37,42,44,45]. Whilst the exact mechanisms of silver toxicity are
still unclear, this study has shown that extracellular thiols
inactivate Ag+ toxicity to both prokaryotic and eukaryotic cells.
By understanding the mechanisms of silver toxicity and the
inactivation of this by thiols, it may be possible to design silver-
based antibacterial coatings with improved efficacy and reduced
cytotoxicity in vivo.
Conclusions
In conclusion, we have demonstrated that biologically relevant
compounds that contain reduced thiol groups such as GSH and
cysteine, and other human blood components, significantly reduce
the toxicity of silver ions to clinically relevant bacteria and human
dermal fibroblasts (skin cells). These findings have important
implications for the development and testing of novel antimicro-
bial coatings, particularly those intended for use in environments
exposed to biological tissues or secretions such as wound dressings
and indwelling medical devices.
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